The high stromal SPARC expression is independently associated with poor survival of patients with resected pancreatic ductal adenocarcinoma treated with adjuvant gemcitabine in combination with S-1 or adjuvant gemcitabine alone

Autor: Shintakuya, Ryuta, Kondo, Naru, Murakami, Yoshiaki, Uemura, Kenichiro, Nakagawa, Naoya, Okano, Keisuke, Takahashi, Shinya, Sueda, Taijiro
Zdroj: In Pancreatology March 2018 18(2):191-197
Databáze: ScienceDirect